Viral mediated neuropeptide y expression in the rat paraventricular nucleus results in obesity

Obesity

Volumn 15, Issue 10, 2007, Pages 2424-2435

  Tiesjema, Birgitte ^a   La Fleur, Susanne E ^a   Luijendijk, Mieneke C M ^a   Brans, Maike A D ^a   Lin, En Ju D ^b   During, Matthew J ^b   Adan, Roger A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Animal models; Central feeding regulation; Hypothalamus; Neuropeptide Y

Indexed keywords

ADIPONECTIN; AGOUTI RELATED PROTEIN; AGOUTI RELATED PROTEIN, RAT; AGOUTI-RELATED PROTEIN, RAT; INSULIN; LEPTIN; NEUROPEPTIDE Y; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL; ANTERIOR HYPOTHALAMUS; ARCUATE NUCLEUS; ARTICLE; BLOOD; BODY COMPOSITION; BODY TEMPERATURE; BODY WEIGHT; GENETIC TRANSFECTION; GENETICS; GLUCOSE TOLERANCE TEST; MALE; METABOLISM; MOTOR ACTIVITY; OBESITY; PHYSIOLOGY; RAT; VIROLOGY; WISTAR RAT;

ADENOVIRIDAE; ADIPONECTIN; AGOUTI-RELATED PROTEIN; ANIMALS; ARCUATE NUCLEUS; BODY COMPOSITION; BODY TEMPERATURE; BODY WEIGHT; GLUCOSE TOLERANCE TEST; INSULIN; LEPTIN; MALE; MOTOR ACTIVITY; NEUROPEPTIDE Y; OBESITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, WISTAR; TRANSFECTION;

AGOUTI; ANIMALIA; RATTUS;

EID: 35648977497     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.288     Document Type: Article

References (55)

1. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 1984;115:427-9.
2. Stanley BG, Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into me paraventricular nucleus. Life Sci. 1984;35:2635-42.
3. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol. 1991;260:R321-7.
4. Egawa M, Yoshimatsu H, Bray GA. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol. 1991;260:R328-34.
5. Leibowitz SF. Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes. Brain Res Bull. 1991;27:333-7.
6. Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, Sainsbury A. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes. 2002; 51:152-8.
7. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML. Neuropeptide Y administered chronically into me lateral ventricle profoundly inhibits both the gonadotropic and me somatotropic axis in intact adult female rats. Endocrinology. 1993;132:224-34.
8. Raposinho PD, Castillo E, d'AUeves V, Broqua P, Prolong FP, Aubert ML. Chronic blockade of me melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. Endocrinology. 2000;141:4419-27.
9. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia. 1994;37:1202-8.
10. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 1993;133: 1753-8.
11. Allen YS, Adrian TE, Allen JM, et al. Neuropeptide Y distribution in the rat brain. Science. 1983;221:877-9.
12. Bai FL, Yamano M, Shiotani Y, et al. An arcuatoparaventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 1985;331:172-5.
13. Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 1985;15:1159-81.
14. Sahu A, Kalra SP, Crowley WR, Kalra PS. Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res. 1988;457:376-8.
15. Stanley BG, Magdalin W, Seirafi A, Thomas WJ, Leibowitz SF. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res. 1993;604:304-17.
16. Currie PJ, Coscina DV. Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypoülalamus. Peptides. 1995;16:599-604.
17. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 1986;7:1189-92.
18. Jolicoeur FB, Bouali SM, Fournier A, St. Pierre S. Mapping of hypothalamic sites involved in the effects of NPY on body temperature and food intake. Brain Res Bull. 1995;36: 125-9.
19. Inui A, Okita M, Nakajima M, et al. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proc Assoc Am Physicians. 1998;110:171-82.
20. Michalkiewicz M, Michalkiewicz T. Developing transgenic neuropeptide Y rats. Methods Mol Biol. 2000;153:73-89.
21. Thiele TE, Marsh DJ, Ste ML, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature. 1998;396:366-9.
22. Gropp E, Shanabrough M, Borok E, et al. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci. 2005;8:1289-91.
23. Luquet S, Perez FA, Hnasko TS, Palmiter RD. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science. 2005;310:683-5.
24. Ste ML, Luquet S, Cole TB, Palmiter RD. Modulation of neuropeptide Y expression in adult mice does not affect feeding. Proc Natl Acad Sci USA. 2005;102:18632-7.
25. Passini MA, Watson DJ, Wolfe JH. Gene delivery to the mouse brain with adeno-associated virus. Methods Mol Biol. 2004;246:225-36.
26. Kas MJ, Tiesjema B, van Dijk G, et al. Induction of brainregion-specific forms of obesity by agouti. J Neurosci. 2004; 24:10176-81.
27. Sin M, Walker PD, Bouhamdan M, Quinn JP, Bannon MJ. Preferential expression of an AAV-2 construct in NOS-positive interneurons following intrastriatal injection. Brain Res Mol Brain Res. 2005;141:74-82.
28. During MJ, Young D, Baer K, Lawlor P, Klugmann M. Development and optimization of adeno-associated virus vector transfer into the central nervous system. Methods Mol Med. 2003;76:221-36.
29. Richichi C, Lin EJ, Stefanin D, et al. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci. 2004;24:3051-9.
30. Smidt MP, Smits SM, Bouwmeester H, et al. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development. 2004; 131:1145-55.
31. Nijsen MJ, Croiset G, Stam R, et al. The role of the CRH type 1 receptor in autonomic responses to corticotropinreleasing hormone in me rat. Neuropsychopharmacology. 2000;22:388-99.
32. Kas MJ, van Dijk G, Scheurink AJ, Adan RA. Agoutirelated protein prevents self-starvation. Mol Psychiatry. 2003; 8:235-40.
33. Ericsson A, Schalling M, McIntyre KR, et al. Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc Natl Acad Sci USA. 1987;84:5585-9.
34. Hillebrand JJ, Kas MJ, Scheurink AJ, van Dijk G, Adan RA. AgRP((83-132)) and SHU9119 differently affect activity-based anorexia. Eur Neuropsychopharmacol. 2006; 16:403-12.
35. Segal-Lieberman G, Trombly DJ, Juthani V, Wang X, Maratos-Flier E. NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting. Am J Physiol Endocrinol Metab. 2003;284:E1131-9.
36. Heilig M, Murison R. Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept. 1987;19:221-31.
37. Fuxe K, Agnati LF, Harfstrand A, et al. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scand. 1983; 118:189-92.
38. Karlsson RM, Holmes A, Heilig M, Crawley JN. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav. 2005;80:427-36.
39. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol. 1994; 266:R1765-70.
40. Marks JL, Waite K, Davies L. Intracerebroventricular neuropeptide Y produces hyperinsulinemia in the presence and absence of food. Physiol Behav. 1996;60:685-92.
41. Moltz JH, McDonald JK. Neuropeptide Y: direct and indirect action on insulin secretion in the rat. Peptides. 1985;6: 1155-9.
42. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia. 1996;39:353-6.
43. Harfstrand A. Intraventricular administration of neuropeptide Y (NPY) induces hypotension, bradycardia and bradypnoea in the awake unrestrained male rat: counteraction by NPY-induced feeding behaviour. Acta Physiol Scand. 1986; 128:121-3.
44. Buijs RM, Chun SJ, Niijima A, Romijn HJ, Nagai K. Parasympametic and sympathetic control of the pancreas: a role for me suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J Comp Neurol. 2001;431:405-23.
45. Kenney MJ, Weiss ML, Haywood JR. The paraventricular nucleus: an important component of the central neurocircuitry regulating sympathetic nerve outflow. Acta Physiol Scand. 2003;177:7-15.
46. Bamshad M, Aoki VT, Adkison MG, Warren WS, Bartness TJ. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am J Physiol. 1998;275:R291-9.
47. Bartness TJ, Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol. 1998;275:R1399-411.
48. Evans BA, Agar L, Summers RJ. The role of the sympathetic nervous system in the regulation of leptin synthesis in C57BL/6 mice. FEBS Lett. 1999;444:149-54.
49. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adiposespecific gene dysregulated in obesity. J Biol Chem. 1996;271: 10697-703.
50. Trayhurn P, Duncan JS, Hoggard N, Rayner DV. Regulation of leptin production: a dominant role for the sympathetic nervous system? Proc Nutr Soc. 1998;57:413-9.
51. Sainsbury A, Rohner-Jeanrenaud F, Grouzmann E, Jeanrenaud B. Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. Neuroendocrinotogy. 1996;63:318-26.
52. La Fleur SE, Akana SF, Manalo SL, Dallman MF. Interaction between corticosterone and insulin in obesity: regulation of lard intake and fat stores. Endocrinology. 2004;145: 2174-85.
53. Patel HR, Qi Y, Hawkins EJ, et al. Neuropeptide y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Diabetes. 2006;55:3091-8.
54. Combs TP, Pajvani UB, Berg AH, et al. A transgenic mouse with a deletion in die collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 2004;145:367-83.
55. Spranger J, Verma S, Gohring I, et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes. 2006;55:141-7.